Keraplast has extended distribution of its Replicine™ Functional Keratin®  wound care product range to the Kingdom of Saudi Arabia through the appointment of Tiryaqi Advanced for Trading as exclusive distributor for the region. "We are excited to work with such a dynamic company focused on bringing innovative healthcare solutions to the clinicians in Saudi Arabia" said Dr Rob Kelly, Chief Scientific Officer of Keraplast. "This significantly extends our coverage and ensures patients living with epidermolysis bullosa, or suffering chronic wounds, can access the most advanced solutions available. Our advanced wound care technology is now available on every continent." Dr Mahmoud Salem, Vice President of Tiryaqi added "a high incidence of diabetes means the unmet clinical needs in the areas of chronic wound care in our region is significant, and we focus on bringing the most advanced solutions available to our clinical partners. In addition, to work closely with those families living with epidermolysis bullosa, and offer them the best in class care, is very important for us." For more information contact:

Tel: +966 12 657 2470

Fax:+966 12 651 5218

This email address is being protected from spambots. You need JavaScript enabled to view it./

Web Site: